More on TSHA
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $5.97 |
|
|||
| Open | $5.78 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $6.12 | ||||
| Day Low | $5.72 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 2,848,700 | ||||
- Form 4 Taysha Gene Therapies, For: Jul 10 Filed by: Nagendran Sukumar
- Form 144 Taysha Gene Therapies, Filed by: Nagendran Sukumar
- Taysha Gene Therapies (TSHA) Reiterated at Market Outperform by Citizens
- Taysha Gene Therapies (TSHA) PT Raised to $15 at Baird
- Form 8-K Taysha Gene Therapies, For: Jun 24
- Form 424B5 Taysha Gene Therapies,
- Taysha Gene Therapies to present TSHA-102 data at 2026 Rett meeting
- Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
- Taysha Gene Therapies prices $200M public stock offering
- Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Entities mentioned with TSHA
- FDA | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- 13G | View Related Stories »
- Jefferies & Co | View Related Stories »
- Goldman Sachs | View Related Stories »
- Show More...
